Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
CPI are looking to establish a consultancy framework for an advisor to provide expert contribution to the technology transfer, process development, GMP Preparation and Commercial Manufacture of a self-amplifying RNA Vaccine, in response to the COVID-19 Vaccine manufacture programme. CPI requires support with management of the UK supply chain manufacture of 40 million self-amplifying RNA Vaccine doses, in response to the COVID-19 Vaccine manufacture programme.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| 222 Strategic Consultancy Ltd | 11932011 | £177,898 | - |